Evidence map›Paper›PMID 41395111›Full record

ReviewComputational and structural biotechnology journal2025

Unlocking TRPM7 interactions: A database-driven quest.

Nicolas Jonckheere, Lise Rodat-Despoix, Isabelle Dhennin-Duthille, Alban Girault, Frédéric Hague, Mathieu Gautier

Abstract readReview
In one paragraph

Review in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nicolas JonckheereUniv. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille 59000, France.
Lise Rodat-DespoixUniversité de Picardie Jules Verne, UR-UPJV 4667, Amiens 80000, France.
Isabelle Dhennin-DuthilleUniversité de Picardie Jules Verne, UR-UPJV 4667, Amiens 80000, France.
Alban GiraultUniversité de Picardie Jules Verne, UR-UPJV 4667, Amiens 80000, France.
Frédéric HagueUniversité de Picardie Jules Verne, UR-UPJV 4667, Amiens 80000, France.
Mathieu GautierUniversité de Picardie Jules Verne, UR-UPJV 4667, Amiens 80000, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transient receptor potential cation channel subfamily M member 7 (TRPM7) is a dual function protein comprising a non-selective cation channel and an atypical kinase domain. TRPM7 has been involved in many diseases including malignancies. Indeed, TRPM7 is proposed as a promising target for therapeutical drug design. Numerous studies have shown that TRPM7 interacts with proteins involved in regulating intracellular signaling. Therefore, a better understanding of the TRPM7 interactome would provide insight into pathophysiological mechanisms at the cellular and molecular levels. It could also open up new therapeutic avenues for molecules targeting either the proteins of interest directly or protein-protein interactions. In the first part of this work, we present the interaction partners described in the literature for TRPM7 and their potential impacts on cell biology. In the second part of the manuscript, we use public databases and protein interaction modeling tools to characterize the TRPM7 interactome. In particular, the analysis of the TRPM7 interactome using experimental data (BioGRID) and modeling tools (ProteinPrompt) has allowed us to isolate 19 genes of interest mainly related to small GTPase pathways involved in digestive neoplasia such as colorectal and pancreatic cancers. In summary, we provide an extended overview of potential TRPM7 interactors which need to be validated in cellular models. This will provide crucial insights into the molecular mechanisms at the tumor cell membrane, helping us to propose new therapeutic targets for precision medicine.

Indexed as

BioGRID databaseGSEAProtein interactomeTRPM7

Identifiers

PMID41395111
PMCPMC12699267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.